ELIAS JABBOUR DANDO SURRA NUM LIBERAL

(25:20)

ELIAS JABBOUR ANALISA AS FALAS DE KAKAY E REINALDO AZEVEDO

(9:38)

Elias Jabbour - How I treat the older adult with ALL

(14:30)

Meet leukemia oncologist Elias Jabbour, M.D.

(1:40)

2023 EHA Leukemia Update from Elias Jabbour, MD

(1:48)

Elias Jabbour, MD, on the Phase III PhALLCON Trial in Ph+ ALL

(1:54)

Elias Jabbour, MD shares hot topics at 6th Annual Live Medical Crossfire®: Hematologic Malignancies

(43)

Elias Jabbour, MD invites you to the 6th Annual Live Medical Crossfire®: Hematologic Malignancies

(52)

Elias Jabbour - How I treat CML at MD ANDERSON CANCER CENTER in 2022

(16:32)

Chronic Myeloid Leukemia (CML) Update - Interview with Elias Jabbour, M.D.

(4:22)

Elias Jabbour, MD | Reasons to Attend 2019 ASCO Direct Highlights Denver

(31)

The HemOnc Pulse Live at ASH 2022: Elias Jabbour, MD, on Immunotherapy Advances in ALL

(2:38)

Beyond HCVAD: Exploring Ways to Reduce Myelosuppression - Elias Jabbour, MD

(12:6)

When and how should MRD be measured in Philadelphia-negative ALL?

(3:27)

Dr. Jabbour on Emerging Subsets in ALL

(1:33)

\

(4:25)

Elias Jabbour MD | Advice on Leukemia Cancers at 2019 ASCO Direct Highlights Denver

(43)

King Hussein Award for Cancer Research 2022 - Professor Elias Jabbour

(1:12)

Dr. Elias Jabbour on Blinatumomab for ALL

(1:54)

HEM-ONC CHAT: Dr. Elias Jabbour, 'Treatment a la Carte in CML'

(4:23)